ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BOLT Bolt Biotherapeutics Inc

1.10
0.00 (0.00%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Bolt Biotherapeutics Inc BOLT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.10 14:00:10
Open Price Low Price High Price Close Price Previous Close
1.12 1.04 1.12 1.10 1.10
more quote information »

Recent News

Date Time Source Heading
22/3/202407:05GLOBEBolt Biotherapeutics Reports Fourth Quarter and Full-Year..
07/3/202405:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202405:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:00GLOBEBolt Biotherapeutics to Present at the TD Cowen 44th Annual..
13/2/202413:41EDGAR2Form SC 13D/A - General statement of acquisition of..
07/2/202405:09EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
21/12/202323:30GLOBEPacira Appoints Frank D. Lee as Chief Executive Officer
14/12/202305:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202323:00GLOBEBolt Biotherapeutics Enrolls First Patient in Phase 2..
10/11/202308:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:08EDGAR2Form 8-K - Current report
10/11/202308:05GLOBEBolt Biotherapeutics Reports Third Quarter 2023 Financial..
07/11/202323:00GLOBEBolt Biotherapeutics to Present at Stifel 2023 Healthcare..
24/10/202301:30GLOBEBolt Biotherapeutics Presents Updated Clinical Data from..
18/10/202322:00GLOBEBolt Biotherapeutics to Present Data at the Society for..
17/10/202322:00GLOBEBolt Biotherapeutics Announces First Patient Dosed in Phase..
16/10/202322:00GLOBEBolt Biotherapeutics to Present New Clinical Data from..
28/9/202321:00GLOBEBolt Biotherapeutics Receives Orphan Drug Designation for..
12/9/202322:05GLOBEBolt Biotherapeutics Announces Issuance of U.S. Patent..
06/9/202306:15GLOBEBolt Biotherapeutics to Participate in September Investor..
08/8/202306:10GLOBEBolt Biotherapeutics Reports Second Quarter 2023 Financial..
08/8/202306:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:06EDGAR2Form 8-K - Current report
03/8/202321:30GLOBEBolt Biotherapeutics Initiates Phase 2 Clinical Studies of..
01/8/202307:27GLOBEBolt Biotherapeutics to Present at BTIG Virtual..
30/5/202322:00PRNUSBioLight announces a joint cooperation agreement with..
26/5/202307:05GLOBEBolt Biotherapeutics Highlights Comprehensive Clinical Data..
12/5/202306:05GLOBEBolt Biotherapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock